These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34352260)

  • 1. Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases.
    Shastri MD; Allam VSRR; Shukla SD; Jha NK; Paudel KR; Peterson GM; Patel RP; Hansbro PM; Chellappan DK; Dua K
    Life Sci; 2021 Oct; 283():119871. PubMed ID: 34352260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice.
    Li BWS; de Bruijn MJW; Lukkes M; van Nimwegen M; Bergen IM; KleinJan A; GeurtsvanKessel CH; Andeweg A; Rimmelzwaan GF; Hendriks RW
    Eur J Immunol; 2019 Jan; 49(1):144-156. PubMed ID: 29762870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza A Virus Infection Causes Chronic Lung Disease Linked to Sites of Active Viral RNA Remnants.
    Keeler SP; Agapov EV; Hinojosa ME; Letvin AN; Wu K; Holtzman MJ
    J Immunol; 2018 Oct; 201(8):2354-2368. PubMed ID: 30209189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery.
    Sharma P; Dhanjal DS; Chopra C; Tambuwala MM; Sohal SS; van der Spek PJ; Sharma HS; Satija S
    Chem Biol Interact; 2022 Sep; 365():110050. PubMed ID: 35917947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases.
    Zhou-Suckow Z; Duerr J; Hagner M; Agrawal R; Mall MA
    Cell Tissue Res; 2017 Mar; 367(3):537-550. PubMed ID: 28108847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease.
    Nakao I; Kanaji S; Ohta S; Matsushita H; Arima K; Yuyama N; Yamaya M; Nakayama K; Kubo H; Watanabe M; Sagara H; Sugiyama K; Tanaka H; Toda S; Hayashi H; Inoue H; Hoshino T; Shiraki A; Inoue M; Suzuki K; Aizawa H; Okinami S; Nagai H; Hasegawa M; Fukuda T; Green ED; Izuhara K
    J Immunol; 2008 May; 180(9):6262-9. PubMed ID: 18424749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-36 Cytokines in Infectious and Non-Infectious Lung Diseases.
    Peñaloza HF; van der Geest R; Ybe JA; Standiford TJ; Lee JS
    Front Immunol; 2021; 12():754702. PubMed ID: 34887860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells.
    Oczypok EA; Milutinovic PS; Alcorn JF; Khare A; Crum LT; Manni ML; Epperly MW; Pawluk AM; Ray A; Oury TD
    J Allergy Clin Immunol; 2015 Sep; 136(3):747-756.e4. PubMed ID: 25930197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-13 as a therapeutic target for respiratory disease.
    Kasaian MT; Miller DK
    Biochem Pharmacol; 2008 Jul; 76(2):147-55. PubMed ID: 18502398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-Immune Cell Interactions for Drug Discovery in Chronic Obstructive Pulmonary Disease.
    Keeler SP; Gerovac BJ; Wu K; Wang X; Chartock JR; Byers DE; Romero AG; Holtzman MJ
    Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S260-S265. PubMed ID: 30759005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
    Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.
    van Rijt L; von Richthofen H; van Ree R
    Semin Immunopathol; 2016 Jul; 38(4):483-96. PubMed ID: 26965110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.
    Ishikawa Y; Yoshimoto T; Nakanishi K
    Int Immunol; 2006 Jun; 18(6):847-55. PubMed ID: 16611648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-9 upregulates mucus expression in the airways.
    Louahed J; Toda M; Jen J; Hamid Q; Renauld JC; Levitt RC; Nicolaides NC
    Am J Respir Cell Mol Biol; 2000 Jun; 22(6):649-56. PubMed ID: 10837360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the IL-33/IL-13 Axis for Respiratory Viral Infections.
    Donovan C; Bourke JE; Vlahos R
    Trends Pharmacol Sci; 2016 Apr; 37(4):252-261. PubMed ID: 26833119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin positively regulates MUC5AC production and secretion induced by interleukin-13 in human bronchial epithelial cells.
    Hao W; Wang J; Zhang Y; Wang Y; Sun L; Han W
    Biochem Biophys Res Commun; 2017 Nov; 493(2):979-984. PubMed ID: 28942146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NF-kappaB activation reduces the tissue effects of transgenic IL-13.
    Chapoval SP; Al-Garawi A; Lora JM; Strickland I; Ma B; Lee PJ; Homer RJ; Ghosh S; Coyle AJ; Elias JA
    J Immunol; 2007 Nov; 179(10):7030-41. PubMed ID: 17982094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17A: A Potential Therapeutic Target in Chronic Lung Diseases.
    Shaikh SB; Prabhu A; Bhandary YP
    Endocr Metab Immune Disord Drug Targets; 2019; 19(7):921-928. PubMed ID: 30652654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory Viral Infections in Chronic Lung Diseases.
    Britto CJ; Brady V; Lee S; Dela Cruz CS
    Clin Chest Med; 2017 Mar; 38(1):87-96. PubMed ID: 28159164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbations of chronic obstructive pulmonary disease and chronic mucus hypersecretion.
    Tesfaigzi Y; Meek P; Lareau S
    Clin Appl Immunol Rev; 2006; 6(1):21-36. PubMed ID: 32288656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.